Treasury Wine FY 2026 slides: EBITS ahead, major US restructuring

Treasury Wine Estates reported FY 2026 EBITS of AUD 492.3m, slightly above the AUD 480–490m guidance range, but posted a statutory net loss of AUD 1,078.7m after AUD 1,308.7m of post-tax material items, mainly US asset impairments (AUD 1,120.6m pre-tax). Net sales fell 12.8% to AUD 2.6b and EBITS margin compressed 700bps to 19.2%, while leverage rose to 2.8x (expected to be the peak) and dividends remain suspended amid deleveraging. Management expects FY 2027 group EBITS to be at least flat (with AUD ~40m Ascent cost savings) alongside progressing customer inventory rebalancing and an Americas strategic review, suggesting improving momentum but near-term pressure from transformation costs.

Analysis

The market should separate the non-cash balance-sheet reset from the recurring earnings stream. The real signal is that management is choosing to sacrifice near-term shipment volume and reported revenue in exchange for a cleaner, higher-margin mix; that usually depresses the multiple in the short run but can re-rate the stock if cash conversion and inventory normalization actually improve. The equity risk is that investors focus on the headline loss and miss that the next leg of value creation is mostly a working-capital story, not an income-statement story.

The second-order winner is the premium portfolio in Asia: if brand health is improving while shipments are being throttled, the channel can be healthier than the P&L implies, which supports pricing power later. The losers are lower-tier U.S. brands, distributors carrying excess inventory, and ancillary supply-chain vendors tied to the old footprint; their pain can persist even if the parent company starts posting cleaner numbers. This also matters for competitors: shelf space and distributor attention released by the U.S. reset should ultimately benefit better-capitalized premium drink names, but only after a lag while the channel digests existing stock.

Consensus seems to be underestimating how much of the write-down is a cleansing event, which could make the stock less fragile over 6-18 months if asset sales and cost-out arrive on schedule. The risk is that FY27 flat guidance becomes a ceiling rather than a bridge: if China inventory clearing slows or U.S. depletions fail to convert into gross margin, leverage will stay elevated and the 'peak debt' narrative will unravel. Near term, the stock can trade more on sentiment around guidance quality than on the statutory loss itself; the falsifier is any sign that leverage does not start falling by the next half-year update or that inventory rebalancing slips again.

Key Decisions for Investors

• Tactically buy TSRYY/TWE on post-print weakness over the next 1-4 weeks; target a 10-15% rebound into the next trading update if management shows real progress on asset sales and working-capital release. Cut if net leverage does not trend below 2.5x by the next half-year update or if China pricing weakens.
• If options liquidity is sufficient, use a call spread on TWE rather than spot equity for a 3-6 month catalyst window. The upside case is a slow re-rating on cash flow and simplification; defined risk is preferable because the bear case is execution delay, not immediate insolvency.
• For credit-focused accounts, prefer Treasury Wine’s senior debt over the equity. The capital structure already reflects peak leverage and suspended dividends, while the equity still carries substantial execution risk from the U.S. reset.
• Do not overreact to the statutory loss headline; wait for the FY27 cadence on inventory normalization, cost savings, and divestment proceeds before adding size. If the next update confirms those three items, the stock can grind higher even with flat reported EBITS.